About the NEI ORM
The NEI Office of Regenerative Medicine (ORM) provides scientific and administrative support to the vision research community. The ORM facilitates collaboration among scientists across the NIH and other federal agencies, academia, and nonprofit and private research sectors. ORM’s goal is to accelerate progress in regenerative medicine for vision.
Resources for Researchers
NIH offers a wealth of resources to support basic and clinical researchers working in the cutting-edge field of regenerative medicine. Learn more
Resources for the Public & Patients
Researchers are exploring how stem cells can be used to treat eye diseases and possibly reverse vision loss. Learn more
Events and Announcements
Funding Opportunity Announcement (FOA) for NEI Audacious Goals Initiative (AGI): Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System released
November 9, 2020 - NEI AGI Roadmapping Workshop
This virtual half-day meeting is by invitation only and will enable an important discussion of the challenges ahead.
November 17, 2020 - Vision Innovation Seminar
Dr. Shane Liddelow: Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury Learn more
Upcoming 3DROC announcement of prize competition award
NEI Audacious Goals Initiative (AGI)
NEI is pushing the boundaries of vision science. By facilitating cross-disciplinary research, the AGI is advancing regenerative medicine to tackle the most devastating and difficult-to-treat eye diseases. Explore the NEI Audacious Goals Initiative (AGI).
NEI 3-D Retina Organoid Challenge (3DROC)
3-D ROC is spurring development of robust systems for modeling retinal diseases and testing new regenerative therapies. Explore the NEI 3-D Retina Organoid Challenge (3DROC).
NEI AMD Integrative Biology Initiative
NEI is taking the first important steps to correlate phenotypes, genotypes, and imaging information in the newly created AMD Integrative Biology Initiative. Explore the NEI AMD Integrative Biology Initiative.
NIH Regenerative Medicine Innovation Project (RMIP)
This trans-NIH effort was established by the 21st Century Cures Act to accelerate progress in the field by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety. Explore the NIH Regenerative Medicine Innovation Project (RMIP).
Steven Becker, Ph.D.